Epigenetic regulation limits competence of pluripotent stem cell‐derived oocytes
The EMBO Journal · 2023
DOI: 10.15252/embj.2023113955 ↗Kurz gefasst
Fachartikel in der Zeitschrift The EMBO Journal, 2023. Verfasst von Eishi Aizawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Health Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Oocytes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EC | ERC | HORIZON EUROPE European Research Council (ERC), European Molecular Biology Organization (EMBO), Novartis Foundation.
Abstract (Originalsprache)
Recent studies have reported the differentiation of pluripotent cells into oocytes in vitro . However, the developmental competence of in vitro ‐generated oocytes remains low. Here, we perform a comprehensive comparison of mouse germ cell development in vitro over all culture steps versus in vivo with the goal to understand mechanisms underlying poor oocyte quality. We show that the in vitro differentiation of primordial germ cells to growing oocytes and subsequent follicle growth is critical for competence for preimplantation development. Systematic transcriptome analysis of single oocytes that were subjected to different culture steps identifies genes that are normally upregulated during oocyte growth to be susceptible for misregulation during in vitro oogenesis. Many misregulated genes are Polycomb targets. Deregulation of Polycomb repression is therefore a key cause and the earliest defect known in in vitro oocyte differentiation. Conversely, structurally normal in vitro ‐derived oocytes fail at zygotic genome activation and show abnormal acquisition of 5‐hydroxymethylcytosine on maternal chromosomes. Our data identify epigenetic regulation at an early stage of oogenesis limiting developmental competence and suggest opportunities for future improvements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Molecular Health Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland.
- RIKEN Center for Biosystems Dynamics Research, Kobe, Japan.
- Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
- Department of Embryology, Nara Medical University, Nara, Japan.
- Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
- Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
ORCID-Profile: Eishi Aizawa, Evgeniy A Ozonov, Yumiko K Kawamura, Charles-Etienne Dumeau, So Nagaoka, Tomoya S Kitajima, Mitinori Saitou, Antoine Hfm Peters, Anton Wutz
Förderung
- EC | ERC | HORIZON EUROPE European Research Council (ERC)
- European Molecular Biology Organization (EMBO)
- Novartis Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF)
- European Research Council
- Stavros Niarchos Foundation
Zitieren
APA
Aizawa, E., Ozonov, E. A., Kawamura, Y. K., Dumeau, C. E., Nagaoka, S., Kitajima, T. S., Saitou, M., Peters, A. H., & Wutz, A. (2023). Epigenetic regulation limits competence of pluripotent stem cell‐derived oocytes. The EMBO Journal. https://doi.org/10.15252/embj.2023113955
Vancouver
Aizawa E, Ozonov EA, Kawamura YK, Dumeau CE, Nagaoka S, Kitajima TS, et al. Epigenetic regulation limits competence of pluripotent stem cell‐derived oocytes. The EMBO Journal. 2023. doi:10.15252/embj.2023113955
BibTeX
@article{Aizawa2023,
author = {Aizawa, Eishi and Ozonov, Evgeniy A and Kawamura, Yumiko K and Dumeau, Charles-Etienne and Nagaoka, So and Kitajima, Tomoya S and Saitou, Mitinori and Peters, Antoine Hfm and Wutz, Anton},
title = {Epigenetic regulation limits competence of pluripotent stem cell‐derived oocytes},
journal = {The EMBO Journal},
year = {2023},
doi = {10.15252/embj.2023113955}
}
EUVIMED